
Biotech Triples Space at Lexington Research Campus
A Cambridge biotech is expanding its suburban presence at the Hayden Research Campus in Lexington with a lease that triples its square-footage to over 93,000 square feet.
A Cambridge biotech is expanding its suburban presence at the Hayden Research Campus in Lexington with a lease that triples its square-footage to over 93,000 square feet.
Dicerna Pharmaceuticals has leased an additional 107,283 square feet at the Hayden Research Campus, bringing its occupancy to more than 275,000 square feet in the town of Lexington.
Life science developer Healthpeak is seeking to develop more lab space at a Waltham property it bought in 2020 for $320 million, providing expansion for existing tenants which include robotics manufacturer Boston Dynamics.
Davis Cos.’ next life science project would bring another 280,000 square feet of office-lab space to the Alewife Quad district in West Cambridge, including a new restaurant in the transforming industrial neighborhood.
Cambridge officials’ debate on a lab construction moratorium in Alewife won’t derail developer Healthpeak’s plans for a 36-acre life science campus, executives said.
Life science developer Healthpeak Properties has acquired a 2.1-acre parcel that could clear the way for construction of a long-sought-after bridge connecting the Quadrangle district with the MBTA’s Alewife station.
With more than $1.9 billion in West Cambridge acquisitions since 2019, the Denver-based REIT Healthpeak Properties is poised to begin testing the city’s appetite for a second Kendall Square-like cluster.
Developer Healthpeak Properties revealed plans to build out a 36-acre life science campus over the next decade on parcels it’s assembling in the Quadrangle section of West Cambridge.
Using data from brokerages Newmark, JLL and Colliers International, plus information from tenant and landlord SEC filings and earnings presentations, Banker & Tradesman has compiled a look at who dominates some of the most active life science submarkets and what’s in the pipeline.
A real estate portfolio spanning nearly 10 acres in the transforming Quadrangle section of West Cambridge is under new ownership following a $180-million transaction.
The field of Greater Boston lab developers is widening. So who are they? What are their strategies? And who have they hired to execute their plans?
Healthpeak Properties is bolstering its position as a major player in Greater Boston life science real estate with a $664 million acquisition that brings its local portfolio up to 2.4 million square feet.
A health care-focused REIT has made its second big-ticket commercial real estate investment in Greater Boston in four months, paying $320 million for a Waltham property redeveloped as tech and life science space.